Five South Koreans die after getting flu shots, sparking vaccine fears

Five people have died after getting flu shots in South Korea in the past week, authorities said, raising concerns over the vaccine's safety.

It comes just as the seasonal inoculation programme is expanded to head off potential COVID-19 complications.

Authorities said there was no reason to believe the deaths were linked to the vaccine but an investigation was underway.

"It makes it hard for us to put out a categorical statement," Vice Health Minister Kim Gang-lip told a briefing on Wednesday about the deaths.

Coming just weeks after the rollout of the national vaccine programme was suspended over safety worries, the deaths have dominated headlines in South Korea.

Officials last month announced plans to procure 20 per cent more flu vaccines for the winter than the previous year to inoculate 30 million people in a bid to prevent the health system being overloaded by patients with flu and COVID-19 exposure.

However, the start of a free jab programme for around 19 million eligible people was suspended for three weeks after it was discovered that some 5 million doses, which need to be refrigerated, had been exposed to room temperature while being transported to a medical facility.

Boosting public trust in vaccines has become a major global challenge this year, as some countries rush to approve experimental COVID-19 vaccines before full safety and efficacy studies have been completed.

South Korea's flu vaccines are supplied by different drugmakers, including LG Chem Ltd and Boryung Biopharma Co. Ltd., a unit of Boryung Pharm Co. Ltd. . A Boryung official told Reuters the company was aware of the reported deaths, but had no immediate comment. LG Chem said the company would follow government advice.

Officials said 8.3 million people have been inoculated with the free flu vaccine since it resumed on October 13, with around 350 cases of adverse reactions reported. The highest number of deaths linked to the seasonal flu vaccination was six in 2005, according to Yonhap news agency.

Even before the coronavirus pandemic, trust in vaccines was a growing challenge for public health bodies. The World Health Organisation named vaccine hesitancy as one of the top 10 global health threats for last year.

In South Korea, a poll earlier this month found that 62 per cent of 2,548 respondents in Gyeonggi province, near Seoul, would not get vaccinated against COVID-19, even if a vaccine is approved, until all safety questions are fully answered.

More from International

  • Powerful winter storm shuts schools, disrupts travel across US Northeast

    Children across parts of the US Northeast will stay home on Monday as a powerful winter storm forced school closures and pushed offices and transit systems onto emergency schedules, with officials across the region warning of dangerous travel conditions.

  • Mexican military kills cartel boss 'El Mencho' in US-backed raid

    One of Mexico's most notorious drug lords, Nemesio Oseguera, or "El Mencho", has been killed in a military raid on Sunday, sparking widespread retaliatory violence.

  • Afghanistan says Pakistan strikes kill and injure dozens

    Pakistan said it launched strikes on targets in Afghanistan after blaming recent suicide bombings, including assaults during the holy month of Ramadan, on fighters it said were operating from its neighbour's territory.

  • Police officer killed, dozens injured in bomb explosions in Ukraine's Lviv

    One police officer was killed and 24 other people were injured after several explosive devices detonated at midnight in Lviv in western Ukraine, the National Police said on Sunday.

  • Trump pivots to new 15% global tariff after Supreme Court setback

    President Donald Trump said on Saturday he will raise a temporary tariff from 10 per cent to 15 per cent on US imports from all countries, the maximum level allowed under the law, after the US Supreme Court struck down his previous tariff programme. The move came less than 24 hours after Trump announced a 10% across-the-board tariff on Friday after the court's decision. The ruling found the president had exceeded his authority when he imposed an array of higher rates under an economic emergency law. The new levies are grounded in a separate but untested law, known as Section 122, that al